ArticleCurrent oncology (Toronto, Ont.)2026

Trastuzumab Deruxtecan in Metastatic Urothelial Carcinoma with NGS-Detected ERBB2 Amplification: A Four-Patient Real-World Case Series.

Giuseppe Di Lorenzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.